Advertisement
Australia markets closed

  • ALL ORDS

    7,837.40
    -100.10 (-1.26%)
     

  • ASX 200

    7,575.90
    -107.10 (-1.39%)
     

  • AUD/USD

    0.6534
    +0.0011 (+0.16%)
     

  • OIL

    84.07
    +0.50 (+0.60%)
     

  • GOLD

    2,360.20
    +17.70 (+0.76%)
     

  • Bitcoin AUD

    98,157.82
    +985.54 (+1.01%)
     

  • CMC Crypto 200

    1,386.34
    -10.19 (-0.73%)
     

  • AUD/EUR

    0.6089
    +0.0016 (+0.26%)
     

  • AUD/NZD

    1.0984
    +0.0027 (+0.25%)
     

  • NZX 50

    11,805.09
    -141.34 (-1.18%)
     

  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     

  • FTSE

    8,116.63
    +37.77 (+0.47%)
     

  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     

  • DAX

    18,048.80
    +131.52 (+0.73%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

New Strong Sell Stocks for May 19th

Zacks Equity Research
·1-min read

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:

ASE Technology Holding Co., Ltd. ASX is a semiconductor packaging and testing company. The Zacks Consensus Estimate for its current year earnings has been revised 5.4% downward over the last 60 days.

CONMED Corporation CNMD is a medical technology company that sells surgical devices. The Zacks Consensus Estimate for its current year earnings has been revised 4% downward over the last 60 days.

Bausch Health Companies Inc. BHC is a pharmaceutical, OTC products and medical devices company . The Zacks Consensus Estimate for its current year earnings has been revised 5.6% downward over the last 60 days.

ADVERTISEMENT

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
CONMED Corporation (CNMD) : Free Stock Analysis Report
 
ASE Technology Holding Co., Ltd. (ASX) : Free Stock Analysis Report
 
Bausch Health Cos Inc. (BHC) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research